Logo
mobilemenu
close
CMN Live
CMN+
Home
Clinical Trials
CRISPRMED
CRISPRMED24
CRISPRMED25
CRISPRMED26
WDC CRISPRMED26 Contest
CRISPRMED Global - Brazil 2026
CRISPRMED Website Policies
EGMEDC
CMN Intelligence
Webinars
CMN Webinars On-demand - All
CMN Webinar - Disrupting the Care of Cardiovascular Disease With Single-Course Gene Editing Medicines
CMN Webinar - Taking the Guesswork Out of Drug Development: CRISPR-Select Validates Drug Targets and Drug Responders Early and Conclusively
CMN Webinar - Clinical-Grade gRNA for Genomic Medicines: Making Sense of the CRISPR Regulatory Landscape
CMN Webinar - Enhancing T Cell Function for Cancer immunotherapy With CRISPR
CMN Webinar - Engineering Approaches to Improve CRISPR Technologies
CMN Webinar - Development of CRISPR/Cas9-based Therapies against Alzheimer's Disease
CMN Webinar - Epigenomic Editing Ameliorates Detrimental Effects of Adolescent Alcohol Exposure
CMN Webinar - Gene Editing for Junctional Epidermolysis Bullosa
CMN Webinar - Multiplexed Genome Regulation In Vivo with Hyper-efficient Cas12a
CMN Webinar - The TCR Therapy Revival
CMN Webinar - Deliver CRISPR to the Brain - A New Treatment Strategy for Mucopolysaccharidoses
CMN Webinar - Controllable Genome Editing With Split-Engineered Base Editors
CMN Webinar - CRISPR-based Control of Insect-borne Diseases
CMN Webinar - CRISPR and MLD
CMN Webinar - CRISPR Off-Targets II
CMN Webinar - Rare Diseases and CRISPR
CMN Webinar - CRISPR On/Off Target
CMN Webinar - CRISPR Off-Targets
CMN Webinar - CRISPR Delivery Systems
CMN Webinar - Certainty After CRISPR
Advertising
WDC
About
search
Selfservice
|
Subscriberlogin
Logout
Prime Editors
Base Editors
Delivery
Safety
Off-target
Microbiome
CAR-T
TIL
Rare Diseases
Trials
Explainers
CMN Weekly
CARBON
Cellectis S.A.
CMN Weekly (19 December 2025) - Your Weekly CRISPR...
CMN Weekly
Dec. 19, 2025
Some of the best links we picked up around the internet
CMN Weekly (12 December 2025) - Your Weekly CRISPR...
CMN Weekly
Dec. 12, 2025
Some of the best links we picked up around the internet
CMN Weekly (28 November 2025) - Your Weekly CRISPR...
CMN Weekly
Nov. 28, 2025
Some of the best links we picked up around the internet
CMN Weekly (21 November 2025) - Your Weekly CRISPR...
CMN Weekly
Nov. 21, 2025
Some of the best links we picked up around the internet
CMN Weekly (14 November 2025) - Your Weekly CRISPR...
CMN Weekly
Nov. 14, 2025
Some of the best links we picked up around the internet
CMN Weekly (24 October 2025) - Your Weekly CRISPR...
CMN Weekly
Oct. 24, 2025
Some of the best links we picked up around the internet
CMN Weekly (17 October 2025) - Your Weekly CRISPR...
CMN Weekly
Oct. 17, 2025
Some of the best links we picked up around the internet
CMN Weekly (8 August 2025) - Your Weekly CRISPR...
CMN Weekly
Aug. 8, 2025
Some of the best links we picked up around the internet
Plus
Cellectis S.A.
Blastic Plasmacytoid Dendritic Cell Neoplasm, BPDCN, (NCT03203369)
Sponsors:
Cellectis S.A.
Indicator
IND Enabling
Phase I
Phase II
Phase III
B-Cell Non-Hodgkin Lymphoma, NHL, (NCT05607420)
Sponsors:
Cellectis S.A.
Indicator
Indicator
IND Enabling
Phase I
Phase II
Phase III
Acute Myeloid Leukaemia, AML, (2018-001018-14)
Sponsors:
Cellectis S.A.
Indicator
IND Enabling
Phase I
Phase II
Phase III
Acute Myeloid Leukaemia, AML, (NCT04106076)
Sponsors:
Cellectis S.A.
Indicator
IND Enabling
Phase I
Phase II
Phase III
Relapsed or Refractory B-cell Acute Lymphoblastic Leukaemia, B-ALL, (NCT04150497)
Sponsors:
Cellectis S.A.
Indicator
IND Enabling
Phase I
Phase II
Phase III
Relapsed or Refractory Acute Myeloid Leukaemia, AML, (NCT03190278)
Sponsors:
Cellectis S.A.
Indicator
IND Enabling
Phase I
Phase II
Phase III
Relapsed or Refractory Multiple Myeloma, MM, (NCT04142619)
Sponsors:
Cellectis S.A.
Indicator
IND Enabling
Phase I
Phase II
Phase III
close
Search CRISPR Medicine